Interview with Carl Firth, CEO, ASLAN Pharmaceuticals
Why did you decide to start your own company? I started my career as a scientist with a real passion for molecular biology, and moved into pharmaceutical R&D working for…
Address: 10 Biopolis Road,Chromos # 05-01. Singapore 138 670,Singapore
Tel: +65 67 22 29 00
Web: http://www.nibr.com/research/developing_world/NITD/about.shtml
Novartis Institute for Tropical Diseases (NITD) is dedicated to finding new medicines to treat neglected, infectious diseases. A small-molecule drug discovery research institute, NITD combines the drug-discovery expertise and cutting-edge technologies of Novartis to fight infectious tropical diseases.
NITD was set up as a public-private partnership between Novartis and the Singapore Economic Development Board (EDB) in 2002. Since then, it has grown to more than 100 researchers and supporting staff, with the following scope of activities: Target discovery, Screen development, Compound optimization, Preclinical development, Proof-of-concept clinical trials.
Why did you decide to start your own company? I started my career as a scientist with a real passion for molecular biology, and moved into pharmaceutical R&D working for…
What is the global R&D vision of Takeda, Japan’s largest pharmaceutical company that recently celebrated its 230th birthday? Takeda’s global R&D vision is committed to the discovery and development of…
What is the presence of Boehringer Ingelheim (BI) in Southeast Asia? In 2009, Boehringer Ingelheim decided to establish a regional operating unit for its human pharmaceutical division (prescription and OTC…
Can you please give our readers a brief introduction of AB SCIEX? AB SCIEX provides scientific solutions for its customers, who are scientists that are dealing with complex chemistry, drug…
How did you start this journey of founding your company— why medical devices and why Biosensors? I have been in the medical devices industry since 1977. Therefore, for these 35…
What prompted you to found TriReme six years ago? I set up companies, so TriReme was not the first. The idea behind TriReme was to provide solutions for complex cases,…
Singapore wants to be seen as a springboard for Asia, but that is a position that other countries in Asia would also like to hold. In general, executives prefer to…
Since the last time we had the pleasure of meeting you, 4 years ago, what have been the main developments and changes in the Singaporean pharmaceutical industry? One of the…
Central Asia, what is Central Asia in the BD perspective? For us, Central Asia includes all the countries in Asia, except Greater China, India and Japan. What have been the…
The company’s current corporate strategy includes a major focus on the Emerging Markets and Asia Pacific (EMAP) region. Concretely, what are the expectations and the main objectives for the Asia…
Please give us an overview of HOYA Surgical Optics and its operations. HOYA Surgical Optics is a global manufacturer of intraocular lenses (IOLs) — the artificial lens that is put…
There has been much hype about emerging markets, especially those in Asia. How important are these markets for GE and what are your respective goals for the next three years?…
See our Cookie Privacy Policy Here
